Updated November 2026

The Peptide
Benchmark

Independent vendor rankings, peptide price comparison, and evidence-graded research profiles in one place. Source-linked data, not vague claims.

431
Vendors Ranked
10,417
Prices Tracked
258
Peptide Profiles
Daily
Refreshed

Vendor Rankings

Vendors ranked by PeptideBenchmark's own scoring model — combining trust evidence, pricing coverage, and third-party review data from Finnrick, Peptide Critic, and Trustpilot.

Vendors Ranked
431

Vendors with enough evidence to earn a score on the board.

Trust Reviewed
140

Curated vendors with catalog, testing-evidence, and transparency assessments.

Current Trustpilot
84

Active profiles tracked; 2 delisted ratings are retained and labeled as historical.

How scoring works

Each vendor's rank score reflects our own evidence: COA coverage, pricing depth, and third-party trust signals from Trustpilot, Finnrick, and Peptide Critic. External sources contribute as bonus signals, not gatekeepers — a vendor with strong PeptideBenchmark evidence can rank without them.

Open full benchmark board
View All Vendor Reviews →

Peptide Price Comparison

Live, format-aware pricing from 138 tracked vendors. Vials use effective $/mg with modeled codes; ready sprays and capsules keep their labeled-dose configurations; IU products show price per 1,000 IU and are never mixed into milligrams.

138
Vendors tracked
Daily
Price refresh
20%
Max coupon discount
Compare prices Browse coupon codes
Public evidence infrastructureNew

Search the certificate, not the claim.

Find source-linked peptide certificates by vendor, compound, laboratory, batch, tested panel, and verification status.

Explore the COA database

How the vendor and testing layers fit together

Start here if you want the shortest path through the site’s trust architecture. The vendor side shows who exposes transparency well, the testing side shows which labs and platforms anchor that evidence, and the bridge shows where those stories actually meet.

Start here for public verification
Janoshik

Start here if you care most about public report verification that ordinary readers can inspect themselves.

Start here for direct consumer flow
Kovera

Good fit when you want a more direct-consumer testing flow with visible pricing and shareable verification behavior.

Start here for classic lab profiles
Freedom / ILS

Better fit when you want classic analytical-lab framing instead of a platform-style public results experience.

Open vendor compare Open testing compare Open bridge view Browse testing directory

Peptides by research area

Explore compounds organized by research area — metabolic, tissue-repair, GH axis, and more — with regulatory context and evidence notes on each profile.

🧪
Hormone signaling research
82 profiles
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
•
Other research areas
57 profiles
Useful overflow for compounds that do not belong to the main editorial buckets.
🔥
Metabolic signaling research
51 profiles
Glucose handling, energy expenditure, and exercise-mimetic compounds studied outside the weight-loss drug lane.
⚖️
Weight-loss / incretin research
42 profiles
GLP-1 agonists, dual and triple agonists, amylin analogs, and related appetite and body-weight signaling compounds.
🦠
Immune / inflammation research
36 profiles
Immune-oriented peptides with more clinical framing than the average research-market profile.
⏳
Longevity / geroscience research
32 profiles
Senolytics, longevity-gene proteins, and peptide bioregulators marketed on lifespan claims that outrun their human data.
🛡️
Neuroprotection research
31 profiles
Neuroprotective and neurotrophic compounds, including brain-derived extracts with regional approvals and little Western trial data.
❤️
Cardiovascular research
25 profiles
Cardiac, vascular, and antifibrotic signaling peptides, most of them investigational or preclinical.
💪
Performance / anabolic research
25 profiles
Performance-adjacent peptides and growth-factor analogs that usually sit outside labeled medical use.
🩹
Tissue-repair research
25 profiles
Tissue-repair, soft-tissue, and gut-oriented peptides commonly discussed in regenerative research contexts.
🧠
Cognitive / nootropic research
22 profiles
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
✨
Dermal / cosmetic research
22 profiles
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
📈
GH axis / secretagogue research
20 profiles
GHRH analogs and secretagogues studied in the growth-hormone axis literature.
🧬
Anti-aging / mitochondrial research
16 profiles
Mitochondrial and cellular-aging compounds where mechanism, speculation, and marketing often collide.

Peptides by where they act

The same library, mapped to the body. Pick a region to open its page: every compound that acts there, with regulatory status and evidence grading.

Trending Peptides

Current profile coverage pulled directly from the peptide collection, mixing FDA-approved medicines with closely watched research compounds.

🔥 HOT
Weight loss
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, showing unprecedented 24.2% weight loss in clinical trials. Expected FDA approval in 2027.
Investigational 1 alias
Trials 35PubMed 213 Medium context
Triple AgonistPhase 3GLP-1GIP
🔥 HOT
Weight loss
Semaglutide
A GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes, chronic weight management, and additional labeled uses depending on brand and indication.
FDA Approved 3 aliases
FDATrials 826PubMed 5.9K High context
GLP-1FDA ApprovedWeight ManagementType 2 Diabetes
🔥 HOT
Weight loss
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes and chronic weight management.
FDA Approved 2 aliases
FDATrials 335PubMed 2.8K High context
GIPGLP-1FDA ApprovedWeight Management
Tissue repair
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market 2 aliases
Also in Performance
Trials 4PubMed 226 Medium context
HealingGut HealthTendon RepairRecovery
🔥 HOT
Weight loss
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational
Also in Hormone
Trials 31PubMed 62 Medium context
CagrilintideSemaglutideAmylinGLP-1
GH axis
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved 2 aliases
Also in Performance
FDATrials 24PubMed 95 High context
GHRHFDA ApprovedBody CompositionHIV Lipodystrophy

From the Blog

Collection-backed notes on benchmark methodology, source quality, and how to interpret peptide vendor signal without overclaiming certainty.

View All Posts →